Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOFLOXACIN vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOFLOXACIN vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOFLOXACIN LEVOMILNACIPRAN
Total FAERS Reports 40,403 1,378
Deaths Reported 2,747 382
Death Rate 6.8% 27.7%
Hospitalizations 13,832 378
Average Patient Age 59.4 yrs 46.4 yrs
% Female Patients 54.7% 80.2%
FDA Approval Date Apr 22, 2020 Feb 4, 2019
Manufacturer BPI LABS LLC Allergan, Inc.
Route OPHTHALMIC ORAL
Marketing Status Discontinued Prescription